全球鑑别诊断市场——行业规模、份额、趋势、机会、预测、治疗类型、使用性别、最终用途、地区、竞争分析 (2018-2028)

全球鑑别诊断市场预计在 2024-2028 年的预测期内以稳定的复合年增长率增长。

这是由于流感、COVID 病、心脏病和传染病等各类疾病在全球的流行率不断上升。 通过在线平台轻鬆获得即时检测产品也将推动预测期内的市场增长。 同样，医疗保健的日益分散化、项目开发的高投资和资金预计将在未来几年推动鑑别诊断市场的增长。 由于慢性病诊断测试的可负担性，预计新兴市场将推动市场增长。 2022 年 1 月，治疗用品管理局 (TGA) 初步批准了 Novavax 的 COVID-19 疫苗（品牌为 Nuvaxovid）在澳大利亚使用。

不断上升的诊断测试

由于诊断数量的增加，人们正在寻求最好的诊断测试来轻鬆检测疾病，这有望在预测期内推动市场增长。 诊断测试在私人或公共实验室进行，这些实验室配备适当的设施，有时配备昂贵的设备，并配备训练有素的合格人员。 在传染病诊断领域，对在最接近患者护理点进行的即时检测的需求不断增长，以帮助护理团队更快地收到更多结果并做出更快、更明智的管理决策。我是要求能够做到。 此外，在分子诊断领域，可以通过极具挑战性的鑑别诊断来检测不同类型的疾病。 政府和各种组织正在医疗保健领域进行研发投资，这是预测期内推动鑑别诊断市场增长的主要因素。 根据国家艾滋病控制组织 (NACO) 的数据，到 2021 年，印度约有 240 万人感染了艾滋病毒。 在所有 HIV 感染者中，女性占 45%，12 岁以下的占 2%。 此外，由于诊所数量的增加，鑑别诊断检测市场的需求也在逐年增加。 根据世界卫生组织（WHO）2021年4月发布的《非传染性疾病关键事实》，慢性病每年导致约4100万人死亡，占全球所有死亡人数的71%。

不断进步的技术进步

诊断技术的进步使医生能够实时评估过程和事件。 物理学和数学进步的临床应用导致了诊断工具的发展。 这些发展将帮助医生做出更准确、侵入性更小且成本更低的诊断，并将在预计的年限内推动市场增长。 对家用诊断套件的需求不断增长预计也将导致技术发展，从而在预测期内实现显着增长。 丹纳赫子公司徕卡显微系统公司 (Leica Microsystems) 宣布将于 2020 年 4 月推出该公司革命性共聚焦显微镜的旗舰平台 STELLARIS。 该平台允许在三个维度上查看活组织和细胞。

市场细分

近期发展

• 2021 年 1 月，罗氏在多个已接受 CE 标誌的国家/地区推出了“Cobas Pulse System”。 该产品是罗氏诊断公司最新一代联网的即时护理解决方案。 最新版本允许进行专业的血糖管理。
• 2021 年 9 月，Ortho Clinical Diagnostics 将在其 Ortho Vision 和 Ortho Vision Max Analyzers 上提供即时自旋交叉配型 (ISXM)，这是一种用于识别输血中受体-供体不匹配的工具，宣布

参与企业

Thermo Fisher Scientific Inc.、Hologic, Inc.、Quidel Corporation.、F. Hoffmann-La Roche Ltd.、Abbott Laboratories, Inc.、Danaher Corporation、Meridian Bioscience Inc. GenMark Diagnostics, Inc.、Sekisui Diagnosis Co. , Ltd.、Luminex Corporation 等是在全球鑑别诊断市场上运营的一些主要公司。

范围：

本报告将全球鑑别诊断市场分为以下几类，以及下面详述的行业趋势：

鑑别诊断市场，按治疗类型：

• 胸痛
• 头痛
• 发烧
• 肺炎
• 高血压
• 疲劳
• 睡眠问题

鑑别诊断市场，按用途：

• 身体健康障碍
• 精神疾病

鑑别诊断市场，按最终用途：

• 医院
• 诊断中心
• 其他

按地区划分的鑑别诊断市场：

• 北美
  • 美国
  • 墨西哥
  • 加拿大
• 欧洲
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙
• 亚太地区
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳大利亚
• 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
• 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 埃及
  • 土耳其人

竞争格局

公司概况：对全球鑑别诊断市场主要参与者的详细分析。

可自定义：

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

• 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析

内容

第 1 章概述

• 市场定义
• 市场范围
  • 目标市场
  • 研究目标年份
  • 主要市场细分

第二章研究方法论

• 调查目的
• 基线调查方法
• 主要行业合作伙伴
• 主要协会和次要信息
• 调查方法
• 数据三角测量和验证
• 假设和限制

第 3 章执行摘要

• 市场概览
• 主要市场细分概述
• 主要市场参与者概览
• 主要地区/国家概览
• 市场驱动因素、挑战和趋势概述

第 4 章 VOC（客户之声）

第 5 章全球鑑别诊断市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按治疗类型（胸痛、头痛、发烧、肺炎、高血压、疲劳、睡眠障碍）
  • 按可用性（身体健康障碍、心理健康障碍）
  • 最终用户（医院、诊断中心等）
  • 按地区
  • 按公司分类（2022 年）
• 产品地图
  • 按治疗类型
  • 按可用性
  • 最终用户
  • 按地区

第六章北美鑑别诊断市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按治疗类型（胸痛、头痛、发烧、肺炎、高血压、疲劳、睡眠障碍）
  • 按可用性（身体健康障碍、心理健康障碍）
  • 最终用户（医院、诊断中心等）
  • 按国家
• 北美：国家/地区分析
  • 美国
  • 加拿大
  • 墨西哥

第七章欧洲鑑别诊断市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按治疗类型（胸痛、头痛、发烧、肺炎、高血压、疲劳、睡眠障碍）
  • 按可用性（身体健康障碍、心理健康障碍）
  • 最终用户（医院、诊断中心等）
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第八章亚太地区鑑别诊断市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按治疗类型（胸痛、头痛、发烧、肺炎、高血压、疲劳、睡眠障碍）
  • 按可用性（身体健康障碍、心理健康障碍）
  • 最终用户（医院、诊断中心等）
  • 按国家
• 亚太地区：国家/地区分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第9章南美鑑别诊断市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按治疗类型（胸痛、头痛、发烧、肺炎、高血压、疲劳、睡眠障碍）
  • 按可用性（身体健康障碍、心理健康障碍）
  • 最终用户（医院、诊断中心等）
  • 按国家
• 南美洲：：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章中东和非洲鑑别诊断市场展望

• 市场规模和预测
  • 按价值观
• 市场份额和预测
  • 按治疗类型（胸痛、头痛、发烧、肺炎、高血压、疲劳、睡眠障碍）
  • 按可用性（身体健康障碍、心理健康障碍）
  • 最终用户（医院、诊断中心等）
  • 按国家
• MEA：国家分析
  • 南非鑑别诊断
  • 沙特阿拉伯鑑别诊断
  • 阿联酋鑑别诊断

第 11 章市场动态

• 司机
• 任务

第12章市场趋势与发展

第 13 章全球鑑别诊断市场：SWOT 分析

第 14 章波特的五力分析

• 行业竞争
• 新进入的可能性
• 供应商的力量
• 客户力量
• 替代品的威胁

第15章竞争格局

• 业务概览
• 提供的产品
• 最新趋势
• 财务信息（公开数据）
• 管理团队
• SWOT 分析
  • Thermo Fisher Scientific Inc.
  • Hologic, Inc.
  • Quidel Corporation.
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories, Inc.
  • Danaher Corporation
  • Meridian Bioscience Inc.
  • GenMark Diagnostics, Inc.
  • Sekisui Diagnostics Co., Ltd.
  • Luminex Corporation.

第16章 战略建议

Global Differential Diagnostics Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing prevalence of various types of diseases such as influenza, COVID diseases, cardiac diseases, and infectious diseases across the globe. Also, the growing accessibility of point-of-care testing products through online platforms will drive the growth of the market in the forecast period. Similarly, growing healthcare decentralization and high investments and funding for project development are expected to enhance the growth of the differential diagnostic market in the coming years. The availability of affordable diagnostic tests for chronic illness in the developing region is anticipated to propel the growth of the market. In January 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for Novavax's COVID-19 vaccine branded as Nuvaxovid for use in Australia.

Rising the Diagnostic Tests

Due to the growing number of diagnostic tests, people are demanding the best diagnostic test which will easily detect diseases and is anticipated to boost the growth of the market during the forecasted period. Diagnostic tests are performed in a private or public laboratory with appropriate equipment and sometimes expensive instrumentation and staffed with trained and qualified personnel. Growing demand for point-of-care testing which occurs at the nearest site of patient care is sought in the field of infectious bacterial diagnostics to allow the care team to receive more results quickly and make immediate and informed management decisions. For molecular diagnosis, different types of diseases can be detected by using challenging differential diagnosis. Governments and different organizations are investing for research and development purposes in the healthcare sector which is a major factor in driving the growth of the differential diagnostics market during the forecasted period. In 2021, according to the National Aids Control Organization (NACO), approximately 2.40 million people in India were infected with HIV. Of the total HIV-infected population 45% were women and 2% were below 12. Also, a growing number of clinics will enhance the demand for differential diagnostic tests market over the years. According to the Non-communicable Diseases Key Facts published by the World Health Organization (WHO) in April 2021, chronic diseases kill around 41 million people each year, which is equivalent to 71% of all deaths worldwide.

Growing Technological Advancements

Growing advancements in diagnostic technology helped physicians to evaluate processes and events in real time. The clinical application of advances in physics and mathematics resulted in the development of diagnostic tools. These developments help physicians to get more accurate, less invasive, and less expensive which will boost the market growth during the forecasted years. Also, the growing demand for diagnostic kits for at-home usage has resulted in technical developments which are expected to create significant growth in the forecast period. Leica Microsystems, a Danaher subsidiary, declared the debut of STELLARIS, the company's flagship platform for its revolutionary confocal microscope, in April 2020. This platform allows the viewing of live tissues and cells in three dimensions.

Market Segmentation

Global Differential Diagnostics Market is segmented into treatment type, usability, end use, and by region. Based on treatment type, the market can be segmented into Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, and Sleep Problems. Based on Usability, the market can be segmented into Systems, Kits, Assays, Reagents, and Consumables. Based on end use, the market can be differentiated into Hospitals, Diagnostic Centers, and Others. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. In terms of country, the United States region is dominating the overall globe in the differential diagnostics market. According to CDC in 2020, 79,611,982 people tested for COVID-19 in the United States. This can be ascribed to the increasingly cost-effective covid-19 testing technology in the healthcare sector.

Recent Development

• In January 2021, Roche introduced its Cobas Pulse System in a few nations that accepted the CE Mark. The item is a networked point-of-care solution from Roche Diagnostics' most recent generation. The most recent release provides expert blood glucose management.
• In September 2021, Ortho Clinical Diagnostics announced that Immediate Spin Crossmatch (ISXM), a tool for identifying recipient and donor incompatibility in blood transfusions, will be made available on the company's Ortho Vision and Ortho Vision Max Analyzers.

Market Players

Thermo Fisher Scientific Inc., Hologic, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc, Danaher Corporation, Meridian Bioscience Inc., GenMark Diagnostics, Inc., Sekisui Diagnostics Co., Ltd., Luminex Corporation. are some of the leading players operating in the Global Differential Diagnostics Market.

Report Scope:

In this report, Global Differential Diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Differential Diagnostics Market, By Treatment Type:

• Chest Pain
• Headache
• Fever
• Pneumonia
• Hypertension
• Fatigue
• Sleep Problems

Differential Diagnostics Market, By Usability:

• Physical Health Disorders
• Mental Health Disorders

Differential Diagnostics Market, By End Use:

• Hospitals
• Diagnostic Centers
• Others

Differential Diagnostics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Differential Diagnostics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Differential Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
  • 5.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
  • 5.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Product Map
  • 5.3.1. By Treatment Type
  • 5.3.2. By Usability
  • 5.3.3. By End Use
  • 5.3.4. By Region

6. North America Differential Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
  • 6.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
  • 6.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Differential Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment Type
      • 6.3.1.2.2. By Usability
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Differential Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment Type
      • 6.3.2.2.2. By Usability
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Differential Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment Type
      • 6.3.3.2.2. By Usability
      • 6.3.3.2.3. By End Use

7. Europe Differential Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
  • 7.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
  • 7.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Differential Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment Type
      • 7.3.1.2.2. By Usability
      • 7.3.1.2.3. By End Use
  • 7.3.2. Germany Differential Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment Type
      • 7.3.2.2.2. By Usability
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Differential Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment Type
      • 7.3.3.2.2. By Usability
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Differential Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Treatment Type
      • 7.3.4.2.2. By Usability
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Differential Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Treatment Type
      • 7.3.5.2.2. By Usability
      • 7.3.5.2.3. By End Use

8. Asia-Pacific Differential Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
  • 8.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
  • 8.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Differential Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment Type
      • 8.3.1.2.2. By Usability
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Differential Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment Type
      • 8.3.2.2.2. By Usability
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Differential Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment Type
      • 8.3.3.2.2. By Usability
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Differential Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Treatment Type
      • 8.3.4.2.2. By Usability
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Differential Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Treatment Type
      • 8.3.5.2.2. By Usability
      • 8.3.5.2.3. By End Use

9. South America Differential Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
  • 9.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
  • 9.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Differential Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment Type
      • 9.3.1.2.2. By Usability
      • 9.3.1.2.3. By End Use
  • 9.3.2. Argentina Differential Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment Type
      • 9.3.2.2.2. By Usability
      • 9.3.2.2.3. By End Use
  • 9.3.3. Colombia Differential Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment Type
      • 9.3.3.2.2. By Usability
      • 9.3.3.2.3. By End Use

10. Middle East and Africa Differential Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
  • 10.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
  • 10.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Differential Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Treatment Type
      • 10.3.1.2.2. By Usability
      • 10.3.1.2.3. By End Use
  • 10.3.2. Saudi Arabia Differential Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Treatment Type
      • 10.3.2.2.2. By Usability
      • 10.3.2.2.3. By End Use
  • 10.3.3. UAE Differential Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Treatment Type
      • 10.3.3.2.2. By Usability
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. Global Differential Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1. Thermo Fisher Scientific Inc.
  • 15.6.2. Hologic, Inc.
  • 15.6.3. Quidel Corporation.
  • 15.6.4. F. Hoffmann-La Roche Ltd.
  • 15.6.5. Abbott Laboratories, Inc.
  • 15.6.6. Danaher Corporation
  • 15.6.7. Meridian Bioscience Inc.
  • 15.6.8. GenMark Diagnostics, Inc.
  • 15.6.9. Sekisui Diagnostics Co., Ltd.
  • 15.6.10. Luminex Corporation.

16. Strategic Recommendations